Non-adherence to treatment of chronic diseases can become a risk factor for heart attacks and strokes
A consortium of over 40 medical entities from Latin America advocates recognizing non-adherence to chronic disease treatments as a modifiable risk factor for cardiovascular events, such as heart attacks and strokes.
Statins: cholesterol reducer is safer than the package insert says
A new meta-analysis published in The Lancet indicates that the benefits of statins in reducing cholesterol levels and preventing cardiovascular events far outweigh the potential risks of side effects, challenging common misconceptions about their safety.
Anvisa approves the use of semaglutide for reducing cardiovascular risk
Brazil's National Health Surveillance Agency (Anvisa) has approved semaglutide for reducing the risk of cardiovascular events, a drug popularized for weight loss efficacy.